eMedevents
  • 142,011+ Medical Conferences
  • 273 Specialties
  • 10,705 Organizers
  • 153,547 Speakers
  • 156 Countries
  • 4,623 Cities
47,337+
CME Conference Registrations Sold
Home  >  Speakers  >  Helen Tayton-martin
Helen Tayton-martin

Helen Tayton-martin

    MBA, PhD
Chief Business Officer | Philadelphia, Pennsylvania    United States of America
Biotechnology, Pharmacy And Medicine
Biotechnology, Pharmacy And Medicine,...More
Spoken at 1 event

Biography :

Dr. Helen Tayton-Martin has over 25 years of experience working within the pharma, biotech and consulting environment in disciplines across preclinical and clinical development, outsourcing, strategic planning, due diligence and business development. She co-founded Adaptimmune from the former company, Avidex Limited, where she had been responsible for commercial development of the soluble TCR program in cancer and HIV from 2005 to 2008.

Dr. Tayton-Martin transitioned to become Adaptimmune's Chief Business Officer in March 2017, having served as its Chief Operating Officer since 2008, a role in which she oversaw the transition of all operations in the company from 5 to 300 staff, through transatlantic growth, multiple clinical, academic and commercial collaborations and private and public financing through to its NASDAQ IPO. Today, she is responsible for optimizing the strategic and commercial opportunity for Adaptimmune's assets, leading on business development and commercial activities. Her role encompasses all aspects of pipeline and technology assessment, strategic portfolio analysis, integrated program management and commercial planning and partnerships, including the company's strategic partnership with GSK.

**********************
** ***** *** ****
 
For speaker's contact information - Contact us

Specialties

Biotechnology, Pharmacy and Medicine

Interested Topics

Biotechnology, Pharmacy and Medicine, Life Science, Pharmaceutical Industry, Technology Transfer, Clinical Development, Oncology, Clinical Trials, Product Development, Medical Device, Drug Development, Drug Discovery

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
Close

Send Message